Investor Relations
Home Diagnostics, Inc. is a leading pure-play manufacturer and marketer in the rapidly growing $7 billion diabetes testing supplies market. The Company's innovative products are uniquely positioned to capitalize on several distribution models and gain market share with competitive price points. National pharmacy chains, distributors and managed care providers choose to co-brand with Home Diagnostics because its affordable, high-performance products deliver significant savings to these distributors and their customers.
Recent Financial Releases
Jul 1, 2009
Home Diagnostics Added to Russell Indexes
Jun 4, 2009
Home Diagnostics to Present at Noble Financial Fifth Annual Equity Conference
Investor Relations Contact
Nick Laudico
The Ruth Group
646-536-7030
nlaudico@theruthgroup.com
| Ticker | HDIX |
| Exchange | NASDAQ | Price | $6.20 |
| Change | - 0.05 |
| Volume | 30,200 |
| Jul 2, 2009 - 4:12 PM ET | |
